| abstract |
The present invention relates to a novel modified macrocyclic compound of the general formula (I) as defined and defined herein, and a process for the preparation thereof for use in the treatment and/or prevention of a condition, in particular a hyperproliferative disorder and/or a virus The use of infectious diseases and/or cardiovascular diseases. The invention further relates to intermediate compounds which are useful in the preparation of such compounds of formula (I). |